SCHEMBL5111547

SCHEMBL5111547

O=c1oc2ccc(Cl)cc2c(O)c1-c1cc2c(=O)oc3ccc(Cl)cc3c2o1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.59
NQO1 P15559 1/20 0.55
MAOB P27338 3/20 0.52
MGAM O43451 6/20 0.48
CDC25A P30304 1/20 0.40
CDC25C P30307 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40
GABRG2 P18507 1/20 0.40
GABRB3 P28472 1/20 0.40
GABRA5 P31644 1/20 0.40
GABRA3 P34903 1/20 0.40
GABRA2 P47869 1/20 0.40
GABRB2 P47870 1/20 0.40
GABRA4 P48169 1/20 0.40
GABRE P78334 1/20 0.40
GABRA6 Q16445 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5120928 0.86 MAOA (0.46) MAOANQO1MAOBMGAMCDC25A
SCHEMBL5118497 0.86 ESR2 (0.49) MAOAMAOBKDM4EHPGDHSD17B10
SCHEMBL5125176 0.84 MAOB (0.56) MAOANQO1MAOBALDH1A1KDM4E
SCHEMBL5114313 0.84 CA12 (0.52) MAOANQO1MAOBGABRPGABRD
SCHEMBL5112059 0.84 NQO1 (0.55) MAOANQO1MAOBCDC25ACDC25C
SCHEMBL5115686 0.81 NQO1 (0.57) MAOANQO1MAOBALDH1A1KDM4E
SCHEMBL5119115 0.81 NQO1 (0.41) MAOANQO1MAOBMGAMKDM4E
SCHEMBL5112054 0.81 CSNK2A2 (0.41) MAOANQO1MAOBALDH1A1KDM4E
SCHEMBL5119551 0.79 NQO1 (0.42) MAOANQO1MAOBALDH1A1KDM4E
SCHEMBL5111292 0.79 KDM4E (0.50) MAOANQO1MAOBALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US claimed
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US claimed
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-7384975-B2 Substituted furochromenes, preparation thereof and their antiinflammatory action GLAXOSMITHKLINE ISTRAZIVACKI CENTAR ZAGREB D.O.O. (HR) 2008-06-10 US disclosed
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2006-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060148889-A1 Substituted furochromenes, preparation thereof and their antiinflammatory action CYP11B2, CYP11B1, LTC4S MAOA 327/4885NQO1 60/4885MAOB 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.